Robert P. Wersto

8.7k total citations · 2 hit papers
91 papers, 7.1k citations indexed

About

Robert P. Wersto is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert P. Wersto has authored 91 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 25 papers in Oncology and 15 papers in Genetics. Recurrent topics in Robert P. Wersto's work include Virus-based gene therapy research (13 papers), Cancer-related Molecular Pathways (11 papers) and Pluripotent Stem Cells Research (9 papers). Robert P. Wersto is often cited by papers focused on Virus-based gene therapy research (13 papers), Cancer-related Molecular Pathways (11 papers) and Pluripotent Stem Cells Research (9 papers). Robert P. Wersto collaborates with scholars based in United States, South Korea and United Kingdom. Robert P. Wersto's co-authors include Leopold G. Koss, Francis J. Chrest, Kenneth R. Boheler, F. Herz, Monica Bodogai, Elise C. Kohn, Arya Biragyn, Prem Seth, Katarzyna Wejksza and Gabriela Kania and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Robert P. Wersto

91 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nestin expression ? a property of multi-lineage progenitor cells?

2004 520 citations Yelena S. Tarasova, Robert P. Wersto et al. profile →
Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells

2011 519 citations Purevdorj B. Olkhanud, Bazarragchaa Damdinsuren et al. Cancer Research profile →

Peers

Countries citing papers authored by Robert P. Wersto

Since Specialization

Citations

This map shows the geographic impact of Robert P. Wersto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Wersto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Wersto more than expected).

Fields of papers citing papers by Robert P. Wersto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Wersto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Wersto. The network helps show where Robert P. Wersto may publish in the future.

Co-authorship network of co-authors of Robert P. Wersto

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Wersto. A scholar is included among the top collaborators of Robert P. Wersto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Wersto. Robert P. Wersto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression 2018 ·Frontiers in Immunology ·Guobing Chen, Kalpana Subedi, (unknown), (unknown), Jian Lü, Jae‐Kwan Kim, (unknown), Robert P. Wersto, Myong‐Hee Sung, Nan‐ping Weng	42
2	Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells 2015 ·Cancer Research ·Monica Bodogai, Kanako Moritoh, Catalina Lee-Chang, Christine Hollander, Cheryl A. Sherman‐Baust, Robert P. Wersto, Yoshihiko Araki, Ichiro Miyoshi, Yang Li, Giorgio Trinchieri, Arya Biragyn	122
3	Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L 2013 ·Cancer Research ·Monica Bodogai, Catalina Lee-Chang, Katarzyna Wejksza, Jinping Lai, Maria J. Merino, Robert P. Wersto, Ronald E. Gress, Andrew C. Chan, Charles Hesdorffer, Arya Biragyn	112
4	A Cell Surfaceome Map for Immunophenotyping and Sorting Pluripotent Stem Cells 2012 ·Molecular & Cellular Proteomics ·Rebekah L. Gundry, Daniel R. Riordon, Yelena S. Tarasova, Sandra Chuppa, (unknown), Ondrej Juhász, (unknown), Samuel Milanovich, Fallon K. Noto, Irina Tchernyshyov, (unknown), Damaris Bausch‐Fluck, Hyun‐Jin Tae, Shannon Marshall, Stephen A. Duncan, Bernd Wollscheid, Robert P. Wersto, Sridhar Rao, Jennifer E. Van Eyk, Kenneth R. Boheler	52
5	MFG‐E8 activates proliferation of vascular smooth muscle cells via integrin signaling 2012 ·Aging Cell ·Mingyi Wang, Zongming Fu, James T. Wu, Jing Zhang, Liqun Jiang, Benjamin Khazan, Richard Telljohann, Mingming Zhao, Alexander W. Krug, Maria Pikilidou, Robert E. Monticone, Robert P. Wersto, Jennifer E. Van Eyk, Edward G. Lakatta	81
6	Cannabinoid Receptor Activation Correlates with the Proapoptotic Action of the β2-Adrenergic Agonist (R,R′)-4-Methoxy-1-Naphthylfenoterol in HepG2 Hepatocarcinoma Cells 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Rajib Paul, Anuradha Ramamoorthy, (unknown), Robert P. Wersto, Lawrence Toll, Lucita Jimenez, Michel Bernier, Irving W. Wainer	16
7	Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells breakdown → 2011 ·Cancer Research ·Purevdorj B. Olkhanud, Bazarragchaa Damdinsuren, Monica Bodogai, Ronald E. Gress, Ranjan Sen, Katarzyna Wejksza, Enkhzol Malchinkhuu, Robert P. Wersto, Arya Biragyn	519
8	RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression 2011 ·Nucleic Acids Research ·Mahesh Ramamoorthy, Takashi Tadokoro, (unknown), Avik K. Ghosh, Robert P. Wersto, Alfred May, Tomasz Kulikowicz, Peter Sýkora, Deborah L. Croteau, Vilhelm A. Bohr	42
9	Nontelomeric TRF2-REST Interaction Modulates Neuronal Gene Silencing and Fate of Tumor and Stem Cells 2008 ·Current Biology ·Peisu Zhang, Michael J. Pazin, Catherine Schwartz, Kevin G. Becker, Robert P. Wersto, (unknown), Mark P. Mattson	66
10	Mitochondrial UCP4 Mediates an Adaptive Shift in Energy Metabolism and Increases the Resistance of Neurons to Metabolic and Oxidative Stress 2006 ·NeuroMolecular Medicine ·Dong Liu, Sic L. Chan, Nadja C. de Souza‐Pinto, (unknown), Robert P. Wersto, Ming Zhan, (unknown), Rafael de Cabo, Mark P. Mattson	155
11	Fibronectin Fragment CH-296 Inhibits Apoptosis and Enhances ex Vivo Gene Transfer by Murine Retrovirus and Human Lentivirus Vectors Independent of Viral Tropism in Nonhuman Primate CD34+ Cells 2001 ·Molecular Therapy ·Robert E. Donahue, Brian P. Sorrentino, Robert G. Hawley, Dong Sung An, Irvin S. Y. Chen, Robert P. Wersto	40
12	Thapsigargin-Induced Gene Expression in Nonexcitable Cells Is Dependent on Calcium Influx 1997 ·Molecular Endocrinology ·Karin Rodland, Robert P. Wersto, Susan A. Hobson, Elise C. Kohn	32
13	Debris compensation of Dna histograms and its effect on S‐phase analysis 1995 ·Cytometry ·Robert P. Wersto, Maryalice Stetler‐Stevenson	17
14	Consequences of p53 Gene Expression by Adenovirus Vector on Cell Cycle Arrest and Apoptosis in Human Aortic Vascular Smooth Muscle Cells 1995 ·Biochemical and Biophysical Research Communications ·Dai Katayose, Robert P. Wersto, Kenneth H. Cowan, Prem Seth	34
15	Direct In Vivo Gene Transfer and Expression in Malignant Cells Using Adenovirus Vectors 1994 ·Human Gene Therapy ·Steven L. Brody, Howard Jaffe, Sung Koo Han, Robert P. Wersto, Ronald G. Crystal	50
16	Influence of human papillomavirus on DNA ploidy determination in genital condylomas 1990 ·Cancer ·Mary S. Chacho, (unknown), Robert P. Wersto, Leopold G. Koss	6
17	Check samples for laboratory self-assessment in DNA flow cytometry. The national cancer institute's flow cytometry network experience 1989 ·Cancer ·John S. Coon, Arline D. Deitch, Ralph W. de Vere White, Leopold G. Koss, Myron R. Melamed, Jay E. Reeder, Ronald S. Weinstein, Robert P. Wersto, Leon L. Wheeless	17
18	Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors 1989 ·Cancer ·Leopold G. Koss, Robert P. Wersto, (unknown), (unknown), F. Herz, Selwyn Z. Freed	60
19	Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's flow cytometry network experience 1988 ·Cancer ·John S. Coon, Arline D. Deitch, (unknown), Leopold G. Koss, Myron R. Melamed, Jay E. Reeder, Ronald S. Weinstein, Leon L. Wheeless, Robert P. Wersto	42
20	Lysophosphatidylcholine cell depolarization: Increased membrane permeability for use in the determination of cell membrane potentials 1984 ·Archives of Biochemistry and Biophysics ·Richard L. Gallo, Robert P. Wersto, Robert H. Notter, Jacob N. Finkelstein	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact